Article
BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
Pathology, research and practice - 1 Nov 2020
Jašek Karin, Váňová Barbora, Grendár Marián, Štanclová Andrea, Szépe Peter, Hornáková Andrea, Holubeková Veronika, Plank Lukáš, Lasabová Zora
Abstract excerpt
BRAF V600E mutations in GISTs are considered to be one of the mutational events in KIT/PDGFRA negative or positive GISTs, respectively. BRAF mutated GISTs usually do not respond to imatinib treatment, even more GISTs with imatinib sensitive KIT mutation. However, they are almost phenotypically and morphologically identical with KIT/PDGFRA positive GISTs. In general, due to the small number of BRAF mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
